Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a report published on Wednesday. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.02 on Wednesday. The firm has a 50-day simple moving average of $0.02 and a two-hundred day simple moving average of $0.03. Calithera Biosciences has a 52 week low of $0.02 and a 52 week high of $0.50.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.